🔎 Trials Near Me

Beranda › Kanker Endometrium › California

Uji klinis Kanker Endometrium di California

73 studi untuk Kanker Endometrium mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • PCR Oncology, Arroyo Grande
  • Mercy Cancer Center - Carmichael, Carmichael
  • Mercy San Juan Medical Center, Carmichael
  • dan 15 lainnya
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • dan 10 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Mercy Cancer Center - Carmichael, Carmichael
  • Mercy San Juan Medical Center, Carmichael
  • Kaiser Permanente Dublin, Dublin
  • dan 26 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07198074

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • University of California - Los Angeles, Los Angeles
Menerima pesertaFase 1
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06218914

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • City of Hope Comprehensive Cancer Center, Duarte
  • The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
  • Chao Family Comprehensive Cancer Center, Orange
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Cedars-Sinai Medical Center, Los Angeles
  • Huntington Memorial Hospital, Pasadena
  • Sutter Medical Center Sacramento, Sacramento
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT05640999

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07229313

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Los Angeles
  • Research Site, Santa Rosa
Menerima pesertaFase 2
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA), Santa Monica
  • Stanford University Medical Center, Stanford
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07114601

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Beverly Hills Cancer Center, Beverly Hills
  • City of Hope Cancer Center, Duarte
  • University of California Irvine Medical Center, Orange
  • dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020), Orange
  • Sansum Clinic (Ridley Tree) ( Site 8007), Solvang
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 17 Sep 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Duarte
  • City of Hope, Irvine, Irvine
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of California, San Diego, La Jolla
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Redwood City, Redwood City
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Santa Monica
  • Research Site, Santa Rosa
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • City of Hope, Duarte
  • START - Los Angeles, Los Angeles
  • Cedars Sinai, Los Angeles
  • dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • Kaiser Permanente SoCal, Irvine
  • CPMC Research Institute, San Francisco
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 9 Sep 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06400472

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Duarte
  • Research Site, Irvine
  • Research Site, La Jolla
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • University of Southern California, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07216105

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • UC San Diego Moores Cancer Center, San Diego
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • START Los Angeles, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • City of Hope, Duarte
  • Stanford, Palo Alto
  • University of California, San Francisco
Menerima pesertaFase 1
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Hoag Family Cancer Institute, Newport Beach
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Duarte
  • Research Site, Irvine
Menerima pesertaFase 1/2
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05797168

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

  • Valkyrie Clinical Trials, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07306559

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • City of Hope National Medical Center, Duarte
  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars Sinai Medical Center, Los Angeles
  • dan 4 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 21 Agu 2026 · NCT05548296

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

  • University of California at Los Angeles, Los Angeles
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 20 Agu 2026 · NCT06538337

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

  • START - Los Angeles, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of California, Los Angeles (UCLA), Los Angeles
  • Stanford Cancer Institute, Stanford University, Palo Alto
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
  • dan 1 lainnya
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Stanford University School of Medicine, Palo Alto
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

  • City of Hope at Arcadia, Arcadia
  • City of Hope Medical Center, Duarte
  • City of Hope at Seacliff, Huntington Beach
  • dan 8 lainnya
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 10 Agu 2026 · NCT07741968

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.